Status:
NOT_YET_RECRUITING
Pulsed Electro-Magnetic Field Therapy for Treatment of Midportion Achilles Tendinopathy
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Mid-portion Achilles Tendinopathy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a multi-centre, randomised, double-blind, placebo-controlled trial with two parallel groups in a 1:1 allocation to study the efficacy of Pulsed Electromagnetic Field Therapy (PEMF) in patients...
Eligibility Criteria
Inclusion
- Adults (\>18 years of age)
- Clinical diagnosis of mid-Achilles tendinopathy
- VISA-A score of \<60
- Ultrasound evidence of Achilles tendinopathy (thickening \>7mm)
Exclusion
- Previous invasive treatment to the Achilles tendon (e.g. rupture repair, PRP injection etc)
- Contraindication to PEMF (e.g. pregnancy, pacemakers)
- Physical or psychological comorbidities impairing the ability to complete assessments (eg neurological deficits etc.)
Key Trial Info
Start Date :
June 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06969859
Start Date
June 1 2025
End Date
December 31 2027
Last Update
May 14 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.